Distinguishing Clinicopathologic Features of Patients with V600E and V600K <i>BRAF</i> -Mutant Metastatic Melanoma — Alexander M. Menzies (2012) | RDL Network
Distinguishing Clinicopathologic Features of Patients with V600E and V600K <i>BRAF</i> -Mutant Metastatic Melanoma
Article 2012 en
Authors
AM
Alexander M. Menzies
LH
Lauren E. Haydu
LV
Lydia Visintin
Abstract
1 min read
Different genotypes exist within BRAF-mutant metastatic melanoma, representing biologically and clinically discrete subtypes, suggesting distinct etiology and behavior.
Alexander M. Menzies, Lauren E. Haydu, Lydia Visintin, Matteo S. Carlino, Julie R. Howle, John F. Thompson, Richard F. Kefford, Richard A Scolyer, Georgina V. Long
Alexander M. Menzies, Lauren E. Haydu, Lydia Visintin, Matteo S. Carlino, Julie R. Howle, John F. Thompson, Richard F. Kefford, Richard A Scolyer, Georgina V. Long
Alexander M. Menzies, Lauren E. Haydu, Lydia Visintin, Matteo S. Carlino, Julie R. Howle, John F. Thompson, Richard F. Kefford, Richard A Scolyer, Georgina V. Long
Alexander M. Menzies, Lauren E. Haydu, Lydia Visintin, Matteo S. Carlino, Julie R. Howle, John F. Thompson, Richard F. Kefford, Richard A Scolyer, Georgina V. Long
Ines Esteves Domingues Pires Da Silva, Kevin Wang, James S. Wilmott, Jeffrey Holst, John Park, Camelia Quek, Matthew Wongchenko, Yibing Yan, Graham J. Mann, Matteo S. Carlino, Richard Kefford, Richard A Scolyer, Jean Yang, Georgina V. Long, Helen Rizos, Alexander M. Menzies
Discussion(0)
No comments yet. Be the first to comment.